Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:16 AM
Ignite Modification Date:
2025-12-25 @ 4:16 AM
NCT ID:
NCT07047820
Eligibility Criteria:
Key Inclusion Criteria:
* Adults who were prescribed and had one successful fill for zuranolone within 12 months following end of pregnancy for the treatment of PPD from June 2025 to May 2026 through CVS Specialty Pharmacy.
* Currently reside in the United States.
* Able to complete the questionnaires independently.
Key Exclusion Criteria:
* Prior fill of zuranolone or brexanolone in last 12 months.
* Participants with 2 or more doses of zuranolone at the time of screening.
* Current or history of bipolar disorder.
* Failure to complete baseline surveys prior to 2nd dose of zuranolone.
* Pregnancy that ended more than 12 months ago.
Other protocol-defined Inclusion/Exclusion criteria may apply.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT07047820
Study Brief:
Protocol Section:
NCT07047820